The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)

Barnett, A.; Krentz, A.; Strojek, K.; Sieradzki, J.; Azizi, F.; Embong, M.; Imamoglu, S.; Perusicova, J.; Uliciansky, V.; Winkler, G.

doi:10.1111/j.1463-1326.2008.00894.x

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)

Atıf İçin Kopyala

Barnett A. H., Krentz A. J., Strojek K., Sieradzki J., Azizi F., Embong M., ...Daha Fazla

DIABETES OBESITY & METABOLISM, cilt.10, sa.12, ss.1239-1247, 2008 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 10 Sayı: 12
Basım Tarihi: 2008
Doi Numarası: 10.1111/j.1463-1326.2008.00894.x
Dergi Adı: DIABETES OBESITY & METABOLISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1239-1247
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: To determine if therapeutic management programmes for type 2 diabetes that include self-monitoring of blood glucose (SMBG) result in greater reductions in glycated haemoglobin (HbA1c) compared with programmes without SMBG in non-insulin requiring patients.